WHO reform up for debate at 66th World Health Assembly
This article was originally published in Clinica
Sparks are likely to fly this week at the 66th World Health Assembly as World Health Organization member states thrash out potential ways of reforming the WHO itself.
You may also be interested in...
Meindert Boysen, head of NICE’s Centre For Health Technology Evaluation, shares advice for companies aiming to get their medicine to patients. His golden rules: engage in early advice and be more realistic about pricing.
In an exclusive interview with the Pink Sheet, senior NICE director Meindert Boysen reveals the best advice he ever received and how companies whose products are under review can improve their chances of success.
UK HTA body NICE is looking to the future and rethinking its approach to data and how they inform its guidance.